Thank you for considering submitting your manuscript to REC: Interventional Cardiology. The following instructions will guarantee that we have everything necessary for your manuscript to progress without problems through the peer review, production and publication process. Please take time to read and apply them, since doing so will ensure that your manuscript complies with the journal’s requirements.
1. REC: INTERVENTIONAL CARDIOLOGY: DEFINITION AND AIMS
REC: Interventional Cardiology is the official publication of the Hemodynamics and Interventional Cardiology Section (SHCI) of the Spanish Society of Cardiology, part of the Revista Española de Cardiología (REC Publications) family, devoted to the study, prevention and treatment of cardiovascular disease. It is an official journal of the Spanish Society of Cardiology.
REC: Interventional Cardiology is a peer-reviewed bilingual (Spanish and English) quarterly journal, published online with a very limited print edition. The journal is owed by the Spanish Society of Cardiology, and published in collaboration with Permanyer. It is funded entirely by the SHCI. All articles are open access.
REC: Interventional Cardiology publishes articles in the field of interventional cardiology, including both diagnostic and therapeutic aspects of cardiovascular disease related to catheter-based techniques and their multiple variants. The journal publishes peer-reviewed papers on clinical and experimental topics, approved by the editorial committee and in line with editorial policy. The topics covered include diagnostic techniques, percutaneous interventional procedures, drug therapy, laboratory findings and clinical trials, published as original articles, reviews and updates, editorials, editorial comments, case reports, interviews, images in cardiology and scientific letters.
All of the journal’s processes are conducted strictly in accordance with international ethical guidelines on the publication of biomedical research and information, as are the steps taken to ensure the integrity and accuracy of the research published. The journal will investigate any ethical infraction taking all reasonable measures for its prompt resolution, acting with proportionality and if necessary, involving the institutions of origin of those concerned.
The views and opinions expressed in this journal are exclusively those of the authors and not of the Spanish Society of Cardiology, the SCHI or the Publisher. The latter accepts no responsibility for any losses, claims, procedures, costs, expenses, damage or other responsibility of any type or any form arising directly or indirectly from the content of the publication
The online version of REC: Interventional Cardiology is available in English and Spanish. The print edition is published in Spanish only.
2. EDITORIAL PROCESS
REC: Interventional Cardiology follows a double-blind peer review, meaning that both reviewers and authors are anonymous throughout the process. Internal procedures guarantee that this standard is applied to all articles authored by members of the editorial team. Unsolicited original contributions undergo peer review by experts designated by the Editors before their acceptance. Submission of an article to REC: Interventional Cardiology implies that the work is original and has not been previously published nor is it under consideration for publication in another journal. Editorials, and debates must be solicited by the Editor. The priority of these manuscripts will be assessed mainly by the editorial team, which will submit manuscripts to external review if deemed appropriate.
Accepted manuscripts become the property of the Spanish Society of Cardiology and their complete or partial reproduction for commercial purposes must be appropriately authorized. Articles are subject to the CC BY-NC-ND license. The corresponding author must complete the copyright transfer form after manuscript acceptance.
Authors seeking to publish in REC: Interventional Cardiology should submit their manuscripts through the online manuscript management system (https://www.editorialmanager.com/recintvcardiol/).
Once received, the editorial office will check that the manuscript meets the publication guidelines for the type of article submitted. Manuscripts failing to do so will be returned to the author for revision before the editorial process can begin. Manuscripts meeting the requirements are assigned to an Editor and authors are sent a manuscript reference number by e-mail. This number allows authors to track the progress of their manuscripts through the authors’ menu. Please quote this reference number in any communications with the editorial office.
After the peer-review process, the corresponding author will be notified of the editorial decision, which can be any of the following: a) request for revision, b) rejection, or c) acceptance. a) If modifications are requested, authors are given a deadline for the return of the revised manuscript. Revised manuscripts must be accompanied by the authors’ response to reviewers. The editorial office will return the manuscript for further revision if the requirements are not met. b) If the editorial decision is rejection, a new version of the manuscript cannot be submitted unless authorized by the editorial team after an appeal (7. INQUIRIES, CORRECTIONS, AND APPEALS). c) If the manuscript is accepted for publication, it will be pre-edited by the editorial office. In this phase, the authors may receive a new request to make further stylistic changes.
Once the provisional PDF of the article is ready, the corresponding author is sent the file and asked to check the proofs of the article in the original submission language. At the same time, a final review is made by the editorial office. Once the relevant changes have been incorporated, the article is published as an ahead of print version and the editing of the complementary language begins. Finally, the article is published in a specific issue of the journal, which will depend on editorial scheduling and other criteria.
REC: Publications does not consider preprints as prior publication. Preprints can be sent for evaluation if on submission the authors disclose in the cover letter that the article is a preprint and confirm that it has not been peer-reviewed nor published in an indexed publication. In the same letter they should provide a link to the preprint publication. If the article is finally published, it is the authors’ responsibility to include a link in the preprint version that redirects to the published version.
3. how to prepare an article for REC: INTERVENTIONAL CARDIOLOGY
3.1. Ethical considerations
Authors submitting a manuscript accept full responsibility for its content as defined by the International Committee of Medical Journal Editors.
The research reported in papers submitted to REC: Interventional Cardiology must be carried out in accordance with internationally accepted recommendations for clinical investigation (Declaration of Helsinki of the World Medical Association, revised October 2013).
Studies reporting animal experiments must comply with the ARRIVE guidelines) and be performed in accordance with the United Kingdom Animal (Scientific Procedures) Act 1986 and current national legislation (Royal Decree 53/2013 of 1 February, on basic standards for the protection of experimental animals), and the European Union Directive 2010/63/EU for animals used for scientific purposes, or the guidelines on the care and use of laboratory animals of the National Institutes of Health (NIH Publications, revised 2011: https://grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals.pdf). Authors must clearly state in their manuscripts that they have followed these guidelines.
Systematic reviews and meta-analyses should follow the PRISMA statement criteria (https://doi.org/10.1136/bmj.n71), and patient cases should follow the CARE case report guidelines (https://www.care-statement.org).
Informed consent (if required)
If the work involves the use of human subjects or animals, authors must include a statement that the procedures performed were carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans and the (Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals). The authors must have obtained and filed the informed consent of all the individuals studied and declare in the manuscript that consents are available. The privacy rights of human subjects must always be observed and all information/images must be anonymized to guarantee the protection of personal data.
To facilitate article publication, personal data will be entered into an automatic database belonging to the Spanish Society of Cardiology. Unless otherwise indicated, by submitting their articles, authors expressly authorize that their first name, second name(s), contact address, and e-mail address will be published in REC: Interventional Cardiology in order to acknowledge authorship of the article and to assist readers in contacting them.
3.2. MANDATORY DECLARATIONS
Originality and authorization
Submission of a manuscript implies a) that it has not been previously published (except in the form of an abstract, conference proceeding, academic thesis, or online first publication; b) is not currently submitted for publication elsewhere; c) that its publication has been approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out; and d) that, if accepted, it will not be published for commercial purposes elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright-holder.
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider as prior publication results that are posted in the same clinical trials registry as the primary registration if the results posted are presented in the form of a brief structured abstract or table (less than 500 words). However, dissemination of results in other circumstances (eg, investors’ meetings) is discouraged and may jeopardize consideration of the manuscript. Authors should fully disclose all inclusion in registries of results of the same or closely related work.
To verify originality, the manuscript may be checked by the originality detection service Similarity-Check.
This service is available to the publisher as a member of Crossref, through access to the powerful plagiarism detection software Turnitin, iThenticate.
When including excerpts from other copyrighted works (including figures and tables), the author(s) must obtain written permission from the copyright owners, credit the source(s) in the article and include it in the references section. Permission is to be obtained both for the English and the Spanish version of the article, both in print and electronic format. The journal will not assume any cost or payment related to this.
When an author submits an article to REC: Interventional Cardiology, the journal will send an e-mail to all authors to ensure that they are aware of being named as authors of the manuscript.
Conflicts of interest
All authors must complete the International Committee of Medical Journal Editors conflict of interest form. Declaration of individual conflicts of interest is mandatory at submission of the revised version of the manuscript. During the manuscript submission process, the corresponding author will be responsible for declaring all conflicts of interest related to the article in a specific section for this purpose. If the manuscript is accepted, this information will be included in the final article in a new section entitled Conflicts of interest.
Authors must identify institutions that have provided financial support for the performance of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in data collection, analysis, and interpretation; in drafting the manuscript; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, then this should be stated.
Randomized clinical trials: description and registration
Randomized clinical trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram illustrating patients’ progress through the trial, ie, recruitment, enrollment, randomization, withdrawal, and completion, as well as a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram are available from the CONSORT website.
Registration in a public trials registry is a condition for publication of clinical trials in this journal, in accordance with International Committee of Medical Journal Editors recommendations. Trials must be registered at or before the start of patient enrollment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (eg, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
REC: Interventional Cardiology ascribes to the authorship criteria for scientific articles defined by the International Committee of Medical Journal Editors. Consequently, each person designated as an author must meet all of the following requirements:
- Have substantially contributed to the conception or design of the work or the acquisition, analysis, or interpretation of the data for the work
- Have drafted the work or critically revised it for intellectual content
- Have granted final approval of the version to be published
- Have agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved
Authors wishing to specify the contributions of one or more of the contributing authors within the article must complete the author contributions form and send it with their manuscript using the Cover letter menu item.
Authors are advised to carefully review the list and order of authors before submitting their manuscript at the time of the original submission. Any addition, deletion, or rearrangement of authors’ names in the authorship list should be made through the authorship modification form, providing: a) the reason for the change in author list, and b) written confirmation from all authors that they agree with the addition, removal, or rearrangement. Addition or removal of authors must include confirmation from the author being added or removed. The completed form must be sent through the manuscript management system together with the new version of the article using the Cover letter menu item. The editor assigned to the manuscript will individually review each case.
If the manuscript has already been accepted, the editor will consider the addition, deletion, or rearrangement of authors only in exceptional circumstances. While the editor considers the request, publication of the manuscript will be suspended.
Copyright and authors’ rights
Acceptance of a manuscript for publication implies the automatic transfer of publishing rights to the Spanish Society of Cardiology.
The authors are allowed to reuse, copy, and distribute the material in any medium or format provided that it is for non-commercial purposes and that authorship is duly acknowledged. For commercial use please contact our Publishers (firstname.lastname@example.org).
3.4. open access
REC: Interventional Cardiology is an open access journal, and its content are freely available. Authors are not required to pay for publication of their articles.
All journal content is licensed under a CC BY-NC-ND license.
Its reuse is allowed on the following terms:
– Creative Commons Attribution-NonCommercial-No Derivs (CC BY-NC-ND).
– You may not use the material for commercial purposes. You may copy, redistribute, and include the material in a in a collective work (for example, an anthology), so long as there is no commercial purpose, the material is not altered or modified and the original work is appropriately cited.
3.5. MISCONDUCT IN SCIENTIFIC PUBLICATION
This happens when an article coincides substantially with another previously published by the same authors. This usually happens when articles are simultaneously sent for evaluation to several journals.
Plagiarism is substantially copying the content of someone else’s or one’s own work and presenting it as previously unpublished.
Fabrication or data omission
It is considered misconduct to fabricate or omit relevant data in an investigation with the intention of altering the conclusions of the work. This includes the manipulation or edition of images.
It is the division of a research report into multiple components or pieces and publishing these individual components as separate research articles.
Ghost, guest, or gift authorship
This consists of including in the authorship people who have not participated in the project or who do not meet the requirements of the International Committee of Medical Journal Editors to be considered as an author. This practice usually responds to personal interests or professional ties.
Omission of conflicts of interest or funding
The intentional omission of declare conflicts of interest or funding in order not to compromise the publication of an article.
Publication of studies without informed consent
Patient research always requires the explicit consent of patients or their guardians for the publication of their case, even if the data is completely anonymized. Using patients’ medical information without their consent is considered misconduct in the investigation.
4. INSTRUCTIONS FOR AUTHORS
4.1. MANUSCRIPT SUBMISSION
Manuscripts should be submitted for evaluation by REC: Interventional Cardiology via an online manuscript management system: https://www.editorialmanager.com/recintvcardiol/. Any queries should be addressed to our editorial office: email@example.com; +34 917 242 370.
Our online submission system guides authors step-by-step through the process of entering details related to their articles and uploading their files. The system converts article files to a single PDF used in the blind peer-review process. Authors will receive information on manuscript review by e-mail.
4.2. LANGUAGE AND ONLINE PUBLICATION
This journal is published in Spanish and in English and accepts articles submitted in either of the two languages, but not both. Authors with articles in both languages should submit only one.
Because REC: Interventional Cardiology is a bilingual journal, its editorial processes are complex. To expedite publication time, articles are first published in their original submission language. The process of article production in the complementary language will begin once the first version of the article has been published online (ahead of print).
While the translation of the submitted article is under preparation, it will be available in its original language at ScienceDirect and in the ahead of print section of our website, depending on the language (https://www.recintervcardiol.org/en). Accepted Spanish articles will have to wait for the English version before inclusion in this database.
4.3 GENERAL POINTS
- All manuscripts must adhere to the journal’s instructions. It is understood that the corresponding author takes responsibility for following these instructions and that all coauthors are aware of them, have participated in preparing the manuscript, and fully agree on its content.
- Articles must be submitted in the following format: double-spaced, with 2.5-cm margins, and numbered pages.
- The maximum length of the article encompasses the manuscript word count, including the references, abstract, key points, figure legends, and tables.
- A cover letter should be included with relevant information about the manuscript (eg, originality, authorship, importance of the topic).
- The article submitted for review must comprise at least 2 documents: title page and manuscript.
- To guarantee double-blind review, any information that could identify the authors must be omitted from all files, except the title page and cover letter.
- The title page must include the title, first name(s) and second name(s) of the author(s), authors’ affiliations (department, institution, city, and country), e-mail address of the corresponding author, personal or institutional Twitter account if the authors so wish, conflicts of interests, and funding source(s), as follows:
- Title. Concise and informative. Titles are often used in information retrieval systems (indexes). Avoid abbreviations and formulae where possible.
- Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Provide the authors’ affiliations (where the work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after each author’s name and before the corresponding address. The same letter must precede the institutional information (department, institution, city, and country).
- Corresponding author. Clearly indicate who will handle correspondence at all stages of review, publication, and after publication. Ensure that an e-mail addresses is given and that contact details are kept up-to-date by the corresponding author. The authors can provide a Twitter profile, which will be published as contact information in the accepted article to promote its dissemination. It can be a personal or an institutional account, and it should be agreed between all authors.
- Funding sources. List funding sources in the following standard format required by funding bodies:
- “Funding: This work was supported by X [grant number zzzz]. Indicate all funding sources.”
- It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a regional or national grant, or resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
- If the figures or tables mention a published work, the article should be cited consecutively with the other references, that is, according to its order of appearance in the text, tables, and figures. If the material has been obtained from another publication, it is the authors’ responsibility to obtain the required permission for its translation, reproduction, or adaptation. REC: Interventional Cardiology will not be held responsible for any costs associated with this process.
- Any references contained in the material must adhere to the instructions provided in the References section of these guidelines.
- Any supplementary data must adhere to the guidelines indicated in the Supplementary Data section of these instructions.
- Use of word processing software. It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced during article processing. In particular, do not use the word processor’s options to justify text or to hyphenate words. Any subsections should be clearly identified by using a hierarchy. When preparing tables with a word processor, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. Electronic text should be prepared in a way very similar to that of conventional manuscripts. Note that source files of figures, tables, and text graphics will be required. To avoid unnecessary errors, authors are strongly advised to use the “spell-check” and “grammar-check” functions of their word processor.
- References must follow the format used by the American Medical Association.
- List references numerically, in superscript format, in the order they first appear in the text.
- Do not include mention of personal communications or unpublished data. Such references, however, may be included within parentheses in the text.
- When abstracts are cited, they should be less than 2 years old and should be identified as [abstract] within square brackets after the title.
- In references to medical journals, use the standard abbreviation of the journal title.
- References should be sent as standard text, never as footnotes. The field codes of reference management programs are not acceptable; if the authors have worked with reference management software, the file must be converted to plain text before it is submitted.
Journal article.List all authors. If there are more than 6 authors, list only the first 3, followed by the Latin abbreviation “et al”. Example: Lim HS, Farouque O, Andrianopoulos N, et al. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. J Am Coll Cardiol Intv. 2009;2:146-152.
Ahead of print article.Authors, title, journal, year, web page. Example: Biswas S, Lefkovits J, Liew D, Gale CP, Reid CM, Stub D. Characteristics of national and major regional percutaneous coronary intervention registries: A structured literature review. EuroIntervention. 2018. http://dx.doi.org/10.4244/EIJ-D-18-00434.
Preprints. Authors, title, year, link, and date of last access. Example: Ingino C. Innovación e inteligencia artificial en medicina. OSF Preprints [preprint]. 2019. Available at: https://doi.org/10.31219/osf.io/37fn2. Accessed 5 Jul 2021.
Electronic book.Authors, title [Internet], city, publisher, year, web page. Example: Sobieraj DM, White CM, Kluger J, et al. Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. Available at: https://www.ncbi.nlm.nih.gov/books/NBK83532/.
Book chapter.Authors, chapter title, editors, book title, city, publisher, year, and page numbers. Example: Josephson ME. Intraventricular conduction disturbances. En: Josephson ME, ed. Clinical cardiac electrophysiology. Techniques and interpretations. 3rd ed. Philadelphia: Lippincot Williams & Wilkins; 2002. p. 110-139.
Book.Cite the specific pages. Example: Rothman K, Greenland S. Modern epidemiology. Measures of effect and measures of association. Philadelphia: Lippincott-Raven; 1998. p. 51-70.
Web page. Example: National Institute for Health and Clinical Excellence. Chronic heart failure in adults: management. 2010. Available at: http://www.nice.org.uk/Guidance/cg108. Accessed 6 Dec 2011.
Unpublished conference abstract. Veronesi F, Korfiati A, Buffat R, Raubal M. Assessing accuracy and geographical transferability of machine learning algorithms for environmental modelling (8). In: Agile 2017. 20th Conference on Geo-
Information Science; 2017 May 9-12; Wageningen, The Netherlands. Available at: https://agile-online.org/index.php/programme-2017/accepted-papers-and-posters-2017. Accessed 15 Jun 2017.
Supplement. Example: Malecka-Tendera E, Mazur A. Childhood obesity: a pandemic of the twenty-first century. Int J Obes (Lond). 2006;30(Suppl 2):S1-3.
Database. Example: Base de Datos Clínicos de Atención Primaria (BDCAP). Morbilidad registrada en Atención Primaria. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2020. https://www.sanidad.gob.es/en/estadEstudios/estadisticas/estadisticas/estMinisterio/SIAP/home.htm. Accessed 1 Jun 2022.
4.5 SUPPLEMENTARY DATA
REC: Interventional Cardiology accepts supplementary electronic data to support and improve the presentation of authors’ scientific research. Only material directly relevant to the article content will be considered for e-publication and acceptance of such material will remain at the discretion of the Editors. This material will not be translated, typeset, or proofread. The Editorial Board reserves the right to refuse electronic material not deemed appropriate.
To ensure that submitted material is in the correct format, we recommend the following: text (Word document, maximum 300 kb); images (JPG format, maximum 10 MB); audio (MP3 format, maximum 10 MB); videos (MP4 or AVI format, maximum 10 MB). Authors should submit supplementary data in electronic format through the online manuscript management system as a multimedia file along with the article. Each file should have a concise and descriptive title. This material must also meet all requirements and general ethical responsibilities described in these guidelines.
5. TYPES OF ARTICLE
5.1 ORIGINAL ARTICLES
Authors: There is no specific limit to the number of authors but listing more than 25 will require the assessment/approval of the editorial team.
The inclusion of a central illustration is optional. Please check the “Central illustration” section for details.
Author participation includes each and every one of the following criteria:
- Substantially contributing to the conception or design of the work or the acquisition, analysis, or interpretation of the data for the work.
- Drafting the work or critically revising it
- Granting final approval of the version to be published
- Agreeing to be accountable for all aspects of the work
Length: These articles should not exceed 5000 words (including tables, figure legends and references) and should contain a title of no more than 120 characters and spaces.
The manuscript should be arranged in the following order:
- Structured abstract in English (maximum 300 words) and key words (from 3 to 10). The abstract should be structured in 4 sections: a) Introduction and objectives; b) Methods; c) Results; and d) Conclusions. The abstract should be self-explanatory and should not contain references. Up to 3 abbreviations will be accepted (selected from those most frequently used in the body of the text). Define all abbreviations on first mention in the text, except commonly used units of measure (apart from effect units). Acronyms for the names of studies, trials, registries, and scales can be used without definition on first mention, as long as they are widely used in the literature.
- Table of abbreviations (no more than 6 of the most frequently used in the text).
- Text. The body of the article should consist of the following sections: a) Introduction; b) Methods; c) Results; d) Discussion; and e) Conclusions. Sections should be appropriately subdivided with subheadings.
- Key points. Include the following information at the end of the article:
– What is known about the topic?
Summarize key points on what is known about the research topic (do not exceed 200 words).
– What does this study add?
Summarize the key points on the contribution of the study (do not exceed 200 words).
In addition, articles on study methodology will be considered for publication if they comply with the following:
- Randomized clinical trial
- Approval of the institutional review board or local ethics committee
- Identification of funding source
- Registration of the study with a clinical trial registry (eg, www.clinicaltrials.gov)
5.2 REVIEW ARTICLES
Length: These articles should not exceed 7000 words (including tables, figure legends and references) and should contain a title of no more than 120 characters and spaces.
The manuscript should be arranged in the following order:
- Non-structured abstract in English (maximum 200 words) and key words (3-4).
- Table of abbreviations (no more than 8 of the most frequently used in the text).
- Tables (optional).
- Figure captions and figures (optional).
- Videos (optional).
5.3 CASE REPORTS
These articles include clinical cases in interventional cardiology of special clinical relevance. The text should have two clearly identified parts (presentation and resolution), which will be published as two separate articles (requirements below) If accepted, the editorial team will share the case presentation with an expert to request an article on their approach to the case. Include a title of less than 120 characters, including spaces.
- Case presentation. A maximum of 500 words, up to 6 images and up to 4 videos will be accepted. Do not include references. There should be no more than
6 authors. Do not include the case resolution in this part.
- Case resolution. A maximum of 500 words, up to 6 images and up to 4 videos will be accepted. There should be no more than 6 references. The authors should be the same as those named in the Case presentation.
These manuscripts do not require an abstract, list of abbreviations, or key words.
For obvious reasons the print version will only include text and figures, with mention of videos in the online version.
5.4 IMAGES IN CARDIOLOGY
- No more than 6 authors.
- The title must contain less than 8 words.
- The accompanying text should not exceed 250 words and should contain information of clear relevance, with no bibliographic references or figure captions. All symbols evident in the images should be adequately explained in the accompanying text.
- No more than 3 figures.
- Supplementary data: videos only (optional).
5.5. SCIENTIFIC LETTERS
This sections includes papers including original data and describing the authors’ experience, correspondence related to editorial matters, articles published in REC: Interventional Cardiology, as well as letters which generate scientific debate. Letters in response to articles published in the journal should be submitted within 12 weeks of the publication of the article.
No more than 6 authors. Do not exceed 1000 words (including references) and include a title of less than 120 characters, including spaces. Include up to 2 figures and 1 table.
6. PROOFS OF ACCEPTED ARTICLES
The corresponding author receives the proofs of the article for revision and correction of possible discrepancies or terminology errors. Articles will already have been edited as per the journal guidelines, so no style corrections are be accepted at this point. Page proofs will be sent electronically to the corresponding author in PDF format, which can be annotated. To do this, you will need to download the free Adobe Reader, version 9 (or higher). Instructions on how to annotate PDFs will accompany the proofs. The exact system requirements are given at the Adobe site.
If you do not wish to use the PDF annotation function, you may list the corrections (including replies to the Query Form) and return them by e-mail. Please list your corrections quoting the line number. Please use this proof only to check the typesetting, editing, completeness, and correctness of the text, tables, and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editors. We will do everything possible to get your article published quickly and accurately. It is important to ensure that all corrections are returned to us in a single e-mail: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely the author’s responsibility.
7. INQUIRIES, CORRECTIONS, AND APPEALS
Please contact our editorial office (firstname.lastname@example.org; +34 917 242 370) if you have any questions. For any inquiry or appeal related to the editorial process of your article or the final editorial decision, send an e-mail to the Editor-in-Chief. The Editor-in-Chief will personally review all complaints and appeals, consulting, if necessary, other members of the Editorial Team. We will try to answer any appeals as quickly as possible and within 15 days. Communication will be via e-mail, at the address supplied by the author, or by telephone, if so required by either party.
The journal will use the necessary means to correct the literature and ensure the integrity of the published content. To do so, it shall use the appropriate means (corrections, expressions of concern, retractions) depending on the problem detected and its impact, as soon as possible after the identification of the problem. For retractions, REC: Interv Cardiol follows the COPE guidelines, available at https://doi.org/10.24318/cope.2019.1.4.